The average levels of vascular endothelial growth factor A (VEGFA) in both the tumor tissues and serum of subcutaneous implantation models bearing CXCR7-transfectant HepG2 were significantly higher than that of control (P<0.05) (Figures 4a and b). This evidence concerns the gene ACKR3 and neoplasm.